Skip to main content
Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.
Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.
Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes.
Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium.
C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry.
Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years.
A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience.
Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis.
Altering the course of type 1 diabetes: an update on prevention and new-onset clinical trials.